Boston Scientific (BSX) Revenue — Quarter Ended Jun 30, 2025
Revenue increased in the current quarter compared to both the prior quarter and the same quarter last year. The growth was driven by higher sales across all reporting segments.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q2
Revenue increased in the current quarter compared to both the prior quarter and the same quarter last year. The growth was driven by higher sales across all reporting segments.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$5.1B
Revenue reported for this quarter.
Quarter-over-quarter
+8.5%
Change from the immediately preceding quarter.
Year-over-year
+22.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$18.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $4.2B | +19.3% |
| Dec 31, 2024 | $4.6B | +22.4% |
| Mar 31, 2025 | $4.7B | +20.9% |
| Jun 30, 2025 | $5.1B | +22.8% |
Revenue performance
Reported revenue rose from the immediately preceding quarter, continuing an upward trend. Compared with the same quarter one year earlier, revenue also showed a substantial increase.
Quarterly comparison
The current quarter's revenue exceeded the prior quarter's figure, reflecting sequential growth. On a year-over-year basis, revenue was higher than the same period last year, with all segments contributing to the increase.
What to watch
Monitor whether the sequential revenue growth rate can be sustained in the coming quarters.